Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.640
-0.100 (-5.75%)
Jan 8, 2026, 4:00 PM EST - Market closed
APUS Market Cap
APUS has a market cap or net worth of $20.62 million as of January 8, 2026.
Market Cap
20.62M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since the IPO on December 9, 2025, APUS's market cap has decreased from $26.79M to $20.62M, a decrease of -23.00%. That is a compound annual growth rate of -96.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 21.88M | 6.10% |
| Dec 31, 2025 | 20.62M | -23.00% |
| Dec 9, 2025 | 26.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |